Neurable Open for Business: Scaling Neurotechnology Adoption Through Global OEM Integration
BOSTON--( BUSINESS WIRE)-- Neurable, the leader in AI for noninvasive brain-computer interface (BCI) technology, today announced its official transition to a licensing platform model, allowing global OEM partners to integrate its production-ready BCI technology directly into consumer wearables. This marks a major milestone for both Neurable and the BCI industry, as the company continues to spearhead necessary steps in bringing cognitive-enabled products for everyday use to consumers at scale.
With this next phase of its business, Neurable is closing critical gaps in the BCI market, which is projected to grow from $2.87 billion in 2024 to $15.14 billion by 2035. As a pioneer in the space, Neurable has advanced its technology from concept to pilot to full commercialization, and is now ready to deploy it at scale across consumer technology, gaming, health, defense, and clinical applications, where BCI is quickly becoming an expected standard in next-generation devices.
Neurable’s non-invasive BCI technology uses advanced EEG sensors, signal processing, and AI to decode brain activity. Through Neurable’s licensing platform, OEMs can directly integrate its AI-powered brain-sensing technology into existing hardware, such as headphones, hats, glasses, and headbands, while maintaining full control over product design, user experience, and distribution. Products built on this platform carry the “Powered by Neurable AI” badge, a mark that signifies Neurable’s decade of expertise in AI and brain-signal processing, applied to deliver best-in-class performance, usability, and reliability. Neurable has already successfully integrated its technology and is working with companies across multiple sectors, including HP Inc.’s HyperX, MeSpace, and iMotions, as well as the U.S. Air Force Research Laboratory (AFRL).
“Cognitive technology is becoming the foundational layer in consumer wearables,” said Dr. Ramses Alcaide, CEO of Neurable. “As this shift takes hold, our platform allows partners to move from concept to full-scale integration and deliver products that can understand and adapt to users in real-time across industries.”
To support increasing demand, Neurable has expanded its leadership team across operations, product, business development, and finance.
To learn more about how to work with Neurable, visit neurable.com and our partner page.
About Neurable Inc.
Neurable Inc. is a Boston-based neurotechnology company specializing in developing AI-powered tools for brain signal translation and brain-computer interface technology (BCI). Powered by patented signal processing, years of pioneering research across leading labs and institutions, validation by the U.S. Air Force and Mayo Clinic, and an expert scientific and product team, the Neurable AI platform enables high-performance brain-computer interfaces in everyday devices. Through its licensing platform, Neurable enables OEM to integrate brain-sensing capabilities into existing products, accelerating the adoption of non-invasive BCI across industries.
Neurable is dedicated to creating a world where individuals can better understand their minds, optimize human performance, and conquer the most pressing health challenges of our generation. Neurable’s technology has been deployed across commercial and government sectors, including collaborations with HP Inc.’s HyperX, MeSpace, iMotions, and Healthspan Digital Inc. Backed by over $40 million in funding, Neurable is advancing a future where brain-computer interfaces are seamlessly embedded into the products people use every day. Learn more about Neurable at neurable.com.